CLINICAL_TRIALS
trial_result
· 2019-10-09
Clinical Trial Update: A Study of LY3337641 in Rheumatoid Arthritis [Phase 2]
Summary
Phase 2 study of LY3337641 in rheumatoid arthritis was terminated; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Rheumatoid Arthritis | Phase 2 | Status: TERMINATED | Results posted: 2019-10-09